Literature DB >> 3025069

Cell-mediated cytotoxicity in hepatitis A virus infection.

A Vallbracht, P Gabriel, K Maier, F Hartmann, H J Steinhardt, C Müller, A Wolf, K H Manncke, B Flehmig.   

Abstract

We studied cell-mediated cytotoxicity to hepatitis A virus-infected cells in seven patients with acute type A hepatitis and two controls. Skin fibroblast cultures obtained from the skin biopsies of seven patients after acute hepatitis A virus infection and from two persons without history of current or past hepatitis A virus infection were inoculated with hepatitis A virus. Infection of fibroblast cultures always resulted in an inapparent, persistent infection with production and release of infectious hepatitis A virus. Peripheral blood lymphocytes were collected from the same patients at different times after onset of icterus and were stored in liquid nitrogen. Cytolytic activity of peripheral blood lymphocytes was determined by a microcytotoxicity assay using autologous 51Cr-labeled hepatitis A virus-infected and uninfected target cells. Cytotoxic peripheral blood lymphocytes capable of lysing autologous hepatitis A virus-infected skin fibroblasts were detected in all patients with hepatitis A but were not demonstrable in the controls without antibodies against hepatitis A virus. The clinical course of the hepatitis A virus infection was normal in five patients; and in these patients, cytolytic activity of peripheral blood lymphocytes against hepatitis A virus-infected autologous targets peaked 2 to 3 weeks after onset of icterus. A clinically protracted form of the disease with persistent elevation of aminotransferases for at least 5 months after onset was present in two patients. In these cases, the highest cytolytic activity was demonstrated in peripheral blood lymphocytes collected 8 to 12 weeks after onset of icterus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025069     DOI: 10.1002/hep.1840060614

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

Review 1.  Parenterally acquired non-A non-B hepatitis ten years on: advances in diagnosis and therapy.

Authors:  M R Jacyna; H C Thomas
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 2.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 3.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

5.  Genetic control of hepatitis A severity and susceptibility to allergy.

Authors:  Lucienne Chatenoud; Jean-François Bach
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 6.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

7.  Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A.

Authors:  B Fleischer; S Fleischer; K Maier; K H Wiedmann; M Sacher; H Thaler; A Vallbracht
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

Review 8.  Liver Failure due to Acute Viral Hepatitis (A-E).

Authors:  Paul Manka; Jens Verheyen; Guido Gerken; Ali Canbay
Journal:  Visc Med       Date:  2016-04-07

9.  Virological course of hepatitis A virus as determined by real time RT-PCR: Correlation with biochemical, immunological and genotypic profiles.

Authors:  Zahid Hussain; Bhudev C Das; Syed A Husain; Sunil K Polipalli; Tanzeel Ahmed; Nargis Begum; Subhash Medhi; Alice Verghese; Mohammad Raish; Apiradee Theamboonlers; Yong Poovorawan; Premashis Kar
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

10.  Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.

Authors:  M Kutubuddin; J Simons; M Chow
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.